Arachidonic Acid Market: Market Size & Forecast 2026

Arachidonic acid is a long-chain polyunsaturated fatty acid naturally present in human breast milk and increasingly added to infant formula to support neurological and retinal development in infants. Beyond infant nutrition, ARA is used in dietary supplements, pharmaceuticals, and functional food applications targeting cardiovascular and cognitive health. The market is segmented by source, microbial (fermentation-derived) and animal-based, as well as by application across infant formula, dietary supplements, food and beverage, and pharmaceutical products.

• •Primarily sourced via microbial fermentation using fungi and algae, or extracted from animal tissues such as pork and poultry
• •Regulatory approval required in key markets including the U.S., EU, China, and Japan for infant formula applications
• •Supplied predominantly as an oil or powder, with high purity grades demanded by infant formula manufacturers

The dominant driver of the ARA market remains the global infant formula industry, where ARA is routinely combined with DHA to mimic the fatty acid profile of human breast milk. Rising birth rates in emerging markets, particularly across Asia-Pacific, alongside premiumization of infant nutrition products, are fueling volume demand. Concurrently, the aging global population and growing consumer interest in preventive healthcare are expanding ARA's use in adult dietary supplements targeting joint, cognitive, and cardiovascular wellness.

• •WHO and national health bodies' endorsement of polyunsaturated fatty acid fortification in early-life nutrition
• •Expanding middle-class populations in China, India, and Southeast Asia driving premium infant formula consumption
• •Growing adoption of ARA alongside DHA in sports nutrition and clinical nutrition formulations

By source, the market is split between microbial fermentation, the dominant and fastest-growing segment due to its vegetarian positioning and consistent quality, and animal-derived ARA, which retains niche demand. By application, infant formula accounts for the largest share, with dietary supplements and pharmaceuticals representing meaningful secondary segments. Regionally, Asia-Pacific leads in volume, driven by China, Japan, and Southeast Asia, while North America and Western Europe represent mature, innovation-focused markets.

• •Asia-Pacific is the largest regional market, supported by high infant formula consumption and domestic manufacturing in China and Japan
• •North America leads in per-capita dietary supplement consumption, with strong clinical nutrition demand
• •Europe maintains strict regulatory standards for food fortification, favoring high-quality, compliant ARA supply chains

What are the recent trends and outlook?

Looking ahead, the market is expected to sustain its 4.8% CAGR through 2031, supported by continued penetration of fortified infant formula in developing economies and broadening applications in adult health products. Algae-based ARA production is gaining commercial attention as a fully plant-based, sustainable alternative to traditional microbial fermentation. Regulatory harmonization and increasing approvals for novel food ingredients in markets such as China and Brazil are likely to open new geographic demand channels.

• •Expansion of domestic ARA production capacity in China is expected to reduce import dependency and lower regional prices
• •Rising vegan and clean-label consumer trends are accelerating investment in algae-sourced and vegetarian-certified ARA
• •Strategic mergers and capacity expansions by leading suppliers are anticipated to consolidate market leadership positions